Awakn Life Sciences Announces Signing of Lease for Second Clinic

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF), announced the signing of a five year lease to open Awakn Clinics Trondheim. The new clinic is part of the second stage of Awakn’s Nordic expansion plans, following a move to a larger premises for its Oslo clinic.

Awakn Clinics Trondheim will be a three-treatment room clinic spread over 1,400 square ft and will be situated in the center of Trondheim. The clinic renovations will be finalized in late Q1 2023 with the opening expected next year.

Anthony Tennyson, Awakn’s CEO commented:

“There is real momentum growing for Awakn in Norway. In the space of a week to be able to share news of our move to a new bigger premises in Oslo and an entirely new clinic in Trondheim is very exciting. For so many people who are suffering and in desperate need of a new more effective treatment, this will be great news for them.”

Awakn’s Nordic expansion is being led by its Regional Director of the Nordics, Dr. Lowan Stewart – a renowned figure in the Nordic medical community. He was responsible for the adoption of ketamine therapy into the public healthcare system in Norway. The Trondheim clinic will be led by Dr. Ingrid Casterberg, a prominent and well-respected psychiatrist in Norway.

0 0 votes
Article Rating

The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.

Capital 10X gets down to the real money business, actionable financial insights for traders and investors. We analyze company earnings, interview management teams and help teach the fundamentals of financial analysis and options trading. Our mission is to hunt for genuine 10 baggers.
Notify of

Inline Feedbacks
View all comments